WINTON GROUP Ltd - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$2,531,000
-5.9%
22,628
-38.8%
0.06%
-8.5%
Q1 2020$2,689,000
-19.8%
36,980
+15.1%
0.07%
+51.1%
Q4 2019$3,352,000
+97.3%
32,142
+88.4%
0.05%
+135.0%
Q3 2019$1,699,000
+46.7%
17,064
+143.4%
0.02%
-39.4%
Q1 2018$1,158,0007,0110.03%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$6,8912.63%
VILLERE ST DENIS J & CO LLC 438,161$26,254,6072.24%
RICE HALL JAMES & ASSOCIATES, LLC 282,961$16,955,0231.08%
Chicago Capital, LLC 360,345$21,591,8841.01%
CARDINAL CAPITAL MANAGEMENT LLC /CT 206,399$12,367,4280.53%
Smith, Graham & Co., Investment Advisors, LP 61,849$3,705,9920.46%
Stephens Investment Management Group LLC 467,564$28,016,4350.46%
Jackson Creek Investment Advisors LLC 13,657$8180.34%
Court Place Advisors, LLC 15,133$906,7690.32%
Ziegler Capital Management, LLC 123,158$7,379,1760.30%
View complete list of LIGAND PHARMACEUTICALS INC shareholders